HEENABEN RATHOD: Open Payments
NPI 1417566548 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 34 payments from 12 companies in 2025. Trend: 2023 $564 · 2024 $658 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $176 |
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| Lilly USA, LLC | 5 | $86 |
| Novo Nordisk Inc | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Radius Health, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, Ozempic, MOUNJARO, JARDIANCE, PREVNAR 20, NEXLETOL, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
